New Blood Test for Ovarian Cancer
Lead author Gil Mor, M.D., is an associate professor in the Department of Obstetrics, Gynecology & Reproductive Sciences at Yale School of Medicine in New Haven, Conn.
Yale researchers developed and tested the new blood test.
It's based on four proteins: leptin, prolactin, osteopontin, and insulin-like growth factor-II. If the levels of two or more of these chemicals fall within a certain warning area, the test will predict the patient has cancer.
Researchers tested the screening process on 200 women. Some were already diagnosed with ovarian cancer, and some were healthy.
The test correctly indicated which women had cancer 95 percent of the time and correctly indicated which women did not have cancer 95 percent of the time.
SOURCE: Proceedings of the National Academies of Sciences, published online May 10, 2005
Excerpted from Ivanhoe.com article of May 11, 2005
|Remember we are NOT Doctors and have NO medical training.|
This site is like an Encyclopedia - there are many pages, many links on many topics.
Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.